# Cardinal Health Inc: Form 10-K for the period ended Jun 30, 2024

- Company: [Cardinal Health Inc](/companies/cah.md) (CIK 721371)
- Form: 10-K
- Filed: 2024-08-14
- Accepted by EDGAR: Aug 14, 2024, 08:47 ET
- Period: 2024-06-30
- Accession: 0000721371-24-000056
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000056/cah-20240630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/721371/000072137124000056/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-07-01 to 2024-06-30 | $226.83bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2023-07-01 to 2024-06-30 | $219.41bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2023-07-01 to 2024-06-30 | $7.41bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months, 2023-07-01 to 2024-06-30 | $5.00bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-07-01 to 2024-06-30 | $1.24bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-07-01 to 2024-06-30 | $51.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-07-01 to 2024-06-30 | $348.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-07-01 to 2024-06-30 | $852.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-07-01 to 2024-06-30 | $3.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-07-01 to 2024-06-30 | $3.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-07-01 to 2024-06-30 | 247,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-07-01 to 2024-06-30 | $3.76bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-07-01 to 2024-06-30 | $511.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2023-07-01 to 2024-06-30 | $499.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2023-07-01 to 2024-06-30 | $750.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-06-30 | $5.13bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-06-30 | $34.88bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-06-30 | $45.12bn | us-gaap:Assets |
| Current liabilities | at 2024-06-30 | $35.64bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2024-06-30 | −$3.21bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/721371/000072137124000056/cah-20240630.htm

Filed Aug 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000721371-24-000056. Last ingested by Listed: Nov 5, 2026, 12:30 ET. No prices; not investment advice.